SM

Shahbaz Mustafa Syed

Active Director Director DIN 09493817
DIN 09493817 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shahbaz Mustafa Syed

Data last updated:

Shahbaz Mustafa Syed is a Director at Arkwin Remedies Private Limited (since 2022). The company operates in Chemicals.

DIN 09493817
Primary Designation Director
Industry Chemicals
First Appointment 04 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arkwin Remedies Private Limited U24290MH2022PTC376173
Director04 Feb 20222022Active

Board colleagues of Shahbaz Mustafa Syed

NameDINCompanyDesignation
Aleem Abdul09493815Arkwin Remedies Private LimitedDirector
Mujahed Khan09493816Arkwin Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arkwin Remedies Private Limited
Premium access

Shareholding and investment profile for Shahbaz Mustafa Syed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shahbaz Mustafa Syed

Shahbaz Mustafa Syed currently holds 1 directorship: Arkwin Remedies Private Limited (Director, since 04 Feb 2022).

Shahbaz Mustafa Syed was first appointed on 04 Feb 2022 as Director at Arkwin Remedies Private Limited.

The current boards of Shahbaz Mustafa Syed's companies include Aleem Abdul (Arkwin Remedies Private Limited), Mujahed Khan (Arkwin Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available